- Home
- BLNK vs XOMA Comparison
BLNK vs XOMA Comparison
Compare BLNK & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- XOMA
- Stock Information
- Founded
- BLNK 2009
- XOMA 1981
- Country
- BLNK United States
- XOMA United States
- Employees
- BLNK N/A
- XOMA N/A
- Industry
- BLNK Industrial Specialties
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- XOMA Health Care
- Exchange
- BLNK Nasdaq
- XOMA Nasdaq
- Market Cap
- BLNK 295.1M
- XOMA 320.8M
- IPO Year
- BLNK N/A
- XOMA N/A
- Fundamental
- Price
- BLNK $2.11
- XOMA $28.46
- Analyst Decision
- BLNK Strong Buy
- XOMA Strong Buy
- Analyst Count
- BLNK 7
- XOMA 2
- Target Price
- BLNK $5.79
- XOMA $78.50
- AVG Volume (30 Days)
- BLNK 4.4M
- XOMA 21.5K
- Earning Date
- BLNK 11-07-2024
- XOMA 11-05-2024
- Dividend Yield
- BLNK N/A
- XOMA N/A
- EPS Growth
- BLNK N/A
- XOMA N/A
- EPS
- BLNK N/A
- XOMA N/A
- Revenue
- BLNK $156,918,000.00
- XOMA $15,239,000.00
- Revenue This Year
- BLNK $6.96
- XOMA $456.45
- Revenue Next Year
- BLNK $31.64
- XOMA $29.84
- P/E Ratio
- BLNK N/A
- XOMA N/A
- Revenue Growth
- BLNK 66.29
- XOMA 277.95
- 52 Week Low
- BLNK $1.53
- XOMA $14.27
- 52 Week High
- BLNK $4.66
- XOMA $30.50
- Technical
- Relative Strength Index (RSI)
- BLNK 62.35
- XOMA 53.55
- Support Level
- BLNK $1.63
- XOMA $28.66
- Resistance Level
- BLNK $2.14
- XOMA $30.50
- Average True Range (ATR)
- BLNK 0.12
- XOMA 1.07
- MACD
- BLNK 0.04
- XOMA 0.21
- Stochastic Oscillator
- BLNK 94.12
- XOMA 55.56
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.